Emerging Medication in Australia: A Promising Solution for Obesity Management ?
Australia is currently observing the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor medication , representing a exciting advance in addressing excess weight. Early research findings have demonstrated impressive results, showing greater effectiveness than existing treatments li